Number 5: Early market entry, manufacturing efficiency, and market share are critical to biosimilar development success, while technical complexity and competition heavily impact returns, according to ...

USFDA, via email communication dated 11th April, 2025 (received by Medispray), has classified the inspection at the ...

Divi's Laboratories Limited has announced the signing of long-term manufacturing and supply agreement with a global pharma company for manufacturing and supply of advanced intermediates.

The company's flagship brand - Royal Enfield volumes increased by 24 per cent on a YoY basis in Q4FY25 led by strong demand trends in domestic and export markets.